🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/01/2017 | 57,73 | 58,01 | 57,29 | 57,38 | -0,03% | 1,24% | 9.863.671 |
| 03/01/2017 | 56,44 | 57,61 | 56,35 | 57,40 | +2,17% | 2,25% | 12.564.158 |
| 30/12/2016 | 56,09 | 56,25 | 55,88 | 56,17 | -0,29% | 0,66% | 11.289.685 |
| 29/12/2016 | 56,57 | 56,86 | 56,28 | 56,34 | -0,39% | 1,03% | 6.833.065 |
| 28/12/2016 | 56,98 | 57,12 | 56,50 | 56,56 | -0,87% | 1,09% | 6.470.981 |
| 27/12/2016 | 57,13 | 57,39 | 56,83 | 57,05 | +0,39% | 0,97% | 6.094.749 |
| 23/12/2016 | 57,03 | 57,12 | 56,54 | 56,83 | -0,03% | 1,02% | 7.955.892 |
| 22/12/2016 | 56,89 | 57,25 | 56,45 | 56,85 | +0,25% | 1,41% | 10.584.800 |
| 21/12/2016 | 57,81 | 58,02 | 56,62 | 56,71 | -1,77% | 2,43% | 12.630.706 |
| 20/12/2016 | 58,39 | 58,86 | 57,61 | 57,73 | -1,05% | 2,14% | 10.875.201 |
| 19/12/2016 | 58,97 | 59,42 | 58,08 | 58,34 | -2,08% | 2,27% | 12.512.072 |
| 16/12/2016 | 59,79 | 60,14 | 59,21 | 59,58 | +0,11% | 1,56% | 18.406.758 |
| 15/12/2016 | 59,16 | 59,77 | 59,01 | 59,51 | +0,92% | 1,29% | 8.917.851 |
| 14/12/2016 | 59,02 | 59,89 | 58,77 | 58,97 | +0,02% | 1,89% | 11.612.574 |
| 13/12/2016 | 58,97 | 59,12 | 58,44 | 58,96 | +0,11% | 1,15% | 8.218.626 |
| 12/12/2016 | 58,63 | 59,26 | 58,49 | 58,89 | +0,80% | 1,30% | 8.641.808 |
| 09/12/2016 | 57,72 | 58,69 | 57,63 | 58,43 | +1,85% | 1,83% | 11.021.187 |
| 08/12/2016 | 56,99 | 57,60 | 56,77 | 57,37 | +0,10% | 1,44% | 8.998.757 |
| 07/12/2016 | 56,97 | 57,31 | 55,94 | 57,31 | -0,36% | 2,41% | 14.723.981 |
| 06/12/2016 | 57,42 | 57,62 | 56,88 | 57,52 | +0,05% | 1,30% | 11.171.261 |
| 05/12/2016 | 58,70 | 58,71 | 57,10 | 57,49 | -1,44% | 2,75% | 13.608.490 |
| 02/12/2016 | 58,25 | 58,70 | 57,85 | 58,33 | +0,61% | 1,46% | 8.376.769 |
| 01/12/2016 | 58,49 | 58,56 | 57,87 | 57,98 | -0,70% | 1,17% | 8.802.047 |
| 30/11/2016 | 59,46 | 59,47 | 58,20 | 58,39 | -1,61% | 2,13% | 13.132.174 |
| 29/11/2016 | 59,11 | 59,60 | 59,08 | 59,34 | +0,63% | 0,87% | 10.516.575 |
| 28/11/2016 | 58,95 | 59,22 | 58,80 | 58,97 | -0,66% | 0,71% | 7.806.971 |
| 25/11/2016 | 58,99 | 59,54 | 58,92 | 59,36 | +0,92% | 1,05% | 3.669.362 |
| 23/11/2016 | 57,57 | 58,87 | 57,08 | 58,82 | -0,10% | 3,12% | 9.588.152 |
| 22/11/2016 | 59,64 | 59,78 | 58,41 | 58,87 | -0,96% | 2,30% | 10.052.626 |
| 21/11/2016 | 59,10 | 59,53 | 58,89 | 59,45 | +0,69% | 1,08% | 7.164.862 |